Company: DARE
Filing Date: 2025-08-14
Form Type: S-8
Source: 0001493152-25-011992
Chunk: 0

Company: Dare Bioscience, Inc.
Filing Date: 2025-08-14
Form: S-8
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on August 14, 2025</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

Daré Bioscience, Inc.

(Exact name of registrant as specified in its charter)</div>

| Delaware                              
 (State                                
 or other jurisdiction of              
 incorporation                         
 or organization)                      |     | 20-4139823     
 (I.R.S.        
 employer       
 identification 
 number)        |
| 3655                                  
 Nobel Drive, Suite 260, San Diego, CA 
 (Address                              
 of principal executive offices)       |     | 92122          
 (Zip           
 code)          |

<div align='center'>Daré Bioscience, Inc. 2022 Stock Incentive Plan

(Full title of the plan)

Sabrina Martucci Johnson

President and Chief Executive Officer

Daré Bioscience, Inc.

3655 Nobel Drive, Suite 260

San Diego, CA 92122

(Name and address of agent for service)

(858) 926-7655

(Telephone number, including area code, of agent for service)</div>

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an n emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| Large             
 accelerated filer |     | ☐ |     | Accelerated       
 filer             |     | ☐ |
| Non-accelerated   
 filer             |     | ☒ |     | Smaller           
 reporting company |     | ☒ |
|                   |     |   |     | Emerging          
 growth company    |     | ☐ |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

<div align='center'>EXPLANATORY NOTE</div>

This Registration Statement on Form S